Gemfibrozil reduces plasma prothrombin fragment F1 + 2 concentration, a marker of coagulability, in patients with coronary heart disease - Wilkes, H C; Meade, T W; Barzegar, S; Foley, A J; Hughes, L O; Bauer, K A; Rosenberg, R D; Miller, G J (Thromb Haemostas, 1992)